Endocrine, Metabolic & Immune Disorders - Drug Targets(Formerly Current Dru
ISSN 1871-5303
Visit publication homepage
This journal is devoted to timely reviews of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions. Topics related to the neuroendocrine-immune axis are given special emphasis in view of the growing interest in stress-related, inflammatory, autoimmune, and degenerative disorders.
Publisher: Bentham Science Publishers
- Volume 12
- Number 1, March 2012
- Volume 11
- Number 4, December 2011
- Number 3, September 2011
- Number 2, June 2011
- Number 1, March 2011
- Volume 10
- Number 4, December 2010
- Number 3, September 2010
- Number 2, June 2010
- Number 1, March 2010
- Volume 9
- Number 4, December 2009
- Number 3, September 2009
- Number 2, June 2009
- Number 1, March 2009
- Volume 8
- Number 4, December 2008
- Number 3, September 2008
- Number 2, June 2008
- Number 1, March 2008
- Volume 7
- Number 4, December 2007
- Number 3, September 2007
- Number 2, June 2007
- Number 1, March 2007
- Volume 6
- Number 4, December 2006
- Number 3, September 2006
- Number 2, June 2006
- Number 1, March 2006

Shopping cart


Receive new issue alert